Clinical Trial Update: Proleukin and Rapamune in Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of Proleukin (aldesleukin) and Rapamune (sirolimus) in Type 1 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Proleukin (aldesleukin)
• Rapamune (sirolimus)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED